| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| Do | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 08.12. | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| BPH GLOBAL Aktie jetzt für 0€ handeln | |||||
| 04.12. | BPH GLOBAL LTD: Change of Director's Interest Notices x 4 | - | ASX | ||
| 04.12. | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 02.12. | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 02.12. | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 01.12. | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 01.12. | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 27.11. | BPH GLOBAL LTD: Section 708A Notice | - | ASX | ||
| 27.11. | BPH GLOBAL LTD: Application for quotation of securities - BP8 | - | ASX | ||
| 16.11. | BPH GLOBAL LTD: Record Growth in Seaweed Sales | - | ASX | ||
| 14.11. | BPH GLOBAL LTD: Results of Meeting | - | ASX | ||
| 11.11. | BPH GLOBAL LTD: First-Mover Advantage in Seaweed Male Vitality Formulation | - | ASX | ||
| 06.11. | BPH GLOBAL LTD: BPH Global Strengthens Advisory Board | - | ASX | ||
| 05.11. | BPH Global Enters Exclusive Agreement for Ginseng Formulation | 1 | Finance News Network | ||
| 04.11. | BPH GLOBAL LTD: Exclusive Agreement to Develop Male Performance Product | - | ASX | ||
| 31.10. | BPH GLOBAL LTD: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 26.10. | BPH GLOBAL LTD: Agreement with Indonesian Government for Seaweed Supply | 2 | ASX | ||
| 22.10. | BPH GLOBAL LTD: Positive Rare Earth Elements assays from Seaweed Samples | 1 | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EPIGENOMICS | 0,902 | 0,00 % | PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Epigenomics... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,431 | +3,11 % | Exosomen im Fokus: Wie NurExone neue Wege in der Heilung von Rückenmarksverletzungen geht | ||
| REPLENISH NUTRIENTS | 0,082 | -1,21 % | Replenish Nutrients Holding reports Q3 results | ||
| NEOVACS | 0,010 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.07.2025 | The following instruments on XETRA do have their first trading 18.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.07.2025
Aktien
1 KYG7388C1033 Qunabox Group Ltd.
2... ► Artikel lesen | |
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Resignation of Joint Company Secretary | ||
| TRIVARX | - | - | TRIVARX LTD: Results of General Meeting | ||
| RECCE PHARMACEUTICALS | 0,366 | +5,17 % | Health Check: Recce hits the jackpot with offshore R&D tax concession | ||
| CRISM THERAPEUTICS | - | - | CRISM Therapeutics - Result of Retail Offer | ||
| THX PHARMA | 2,050 | -6,39 % | THERANEXUS: THX Pharma announces the strong success of its approximately EUR 8 million capital increase to support its continued development and strengthen its financial structure | Capital increase of €7.8 million through the issuance of 4,356,804 new shares at a unit price of €1.80
The transaction received strong support from existing shareholders, whose demand on irreducible... ► Artikel lesen | |
| PYC THERAPEUTICS | - | - | PYC THERAPEUTICS LIMITED: Change of Director's Interest Notice | ||
| PATRYS | - | - | PATRYS LIMITED: Letter to Shareholders - General Meeting | ||
| RECURSION PHARMACEUTICALS | 4,770 | +13,57 % | Recursion jumps as J.P. Morgan upgrades on lead program | ||
| QIAGEN | 38,480 | +1,29 % | QIAGEN NV steht still - für mich ist das kein Stillstand! | ||
| IMMUNOME | 20,640 | -11,76 % | Immunome-Aktie fällt nach Ankündigung einer Kapitalerhöhung über 400 Mio. US-Dollar |